Literature DB >> 3346625

Molecular cloning of the major surface antigen of leishmania.

L L Button1, W R McMaster.   

Abstract

The gene encoding gp63, the major surface glycoprotein of Leishmania promastigotes, was isolated from Leishmania major using a synthetic oligonucleotide probe based on the NH2-terminal protein sequence of purified gp63. DNA sequence analysis and the translated amino acid sequence indicate that gp63 is synthesized as precursor molecule having both an NH2-terminal preregion (signal peptide) and an adjacent proregion. This structure is consistent with the protease activity of gp63 since many other proteases are synthesized as precursor forms requiring processing for enzymatic activity. Hybridization studies demonstrated that there are multiple copies of the gp63 gene in the genome of L. major and other Leishmania species. The conservation of the coding sequence of gp63 amongst diverse species of Leishmania provides further support for the importance of gp63 during the life cycle of Leishmania.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3346625      PMCID: PMC2188825          DOI: 10.1084/jem.167.2.724

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  The promastigote surface protease of Leishmania.

Authors:  C Bordier
Journal:  Parasitol Today       Date:  1987-05

2.  Monoclonal antibody affinity purification of a Leishmania membrane glycoprotein and its inhibition of leishmania-macrophage binding.

Authors:  C S Chang; K P Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

Review 3.  Eukaryotic protein modification and membrane attachment via phosphatidylinositol.

Authors:  G A Cross
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

4.  Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.

Authors:  S Henikoff
Journal:  Gene       Date:  1984-06       Impact factor: 3.688

5.  Patterns of amino acids near signal-sequence cleavage sites.

Authors:  G von Heijne
Journal:  Eur J Biochem       Date:  1983-06-01

6.  C3bi receptor (complement receptor type 3) recognizes a region of complement protein C3 containing the sequence Arg-Gly-Asp.

Authors:  S D Wright; P A Reddy; M T Jong; B W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

7.  The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes.

Authors:  D G Russell
Journal:  Eur J Biochem       Date:  1987-04-01

8.  Analysis of closely related genes by the use of synthetic oligonucleotide probes labeled to a high specific activity.

Authors:  L Hellman; U Pettersson
Journal:  Gene Anal Tech       Date:  1987 Jan-Feb

9.  The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages.

Authors:  D G Russell; H Wilhelm
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

10.  Identification of Leishmania genes encoding proteins containing tandemly repeating peptides.

Authors:  A E Wallis; W R McMaster
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

View more
  28 in total

1.  Interaction of Leishmania gp63 with cellular receptors for fibronectin.

Authors:  A Brittingham; G Chen; B S McGwire; K P Chang; D M Mosser
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages.

Authors:  X Liu; K P Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Antibodies raised against synthetic peptides from the Arg-Gly-Asp-containing region of the Leishmania surface protein gp63 cross-react with human C3 and interfere with gp63-mediated binding to macrophages.

Authors:  D G Russell; P Talamas-Rohana; J Zelechowski
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

4.  Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Authors:  Javier Cote-Sierra; Amin Bredan; Carmen M Toldos; Benoit Stijlemans; Lea Brys; Pierre Cornelis; Manuel Segovia; Patrick de Baetselier; Hilde Revets
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice.

Authors:  P J Murray; T W Spithill; E Handman
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

6.  Intracellular glycosylphosphatidylinositols accumulate on endosomes: toxicity of alpha-toxin to Leishmania major.

Authors:  Zhifeng Zheng; Rodney K Tweten; Kojo Mensa-Wilmot
Journal:  Eukaryot Cell       Date:  2005-03

7.  The Leishmania genome comprises 36 chromosomes conserved across widely divergent human pathogenic species.

Authors:  P Wincker; C Ravel; C Blaineau; M Pages; Y Jauffret; J P Dedet; P Bastien
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

8.  Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host.

Authors:  T Aebischer; S F Moody; E Handman
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

9.  gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection.

Authors:  Ileana C Cuevas; Juan J Cazzulo; Daniel O Sánchez
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis.

Authors:  C Fargeas; M Hommel; R Maingon; C Dourado; M Monsigny; R Mayer
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.